Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Shareholders Equity (Quarterly) : -30.14M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.14M |
| March 31, 2026 | -43.80M |
| December 31, 2025 | -30.04M |
| September 30, 2025 | -17.03M |
| June 30, 2025 | -223.00M |
| March 31, 2025 | -216.90M |
| December 31, 2024 | -225.60M |
| September 30, 2024 | -243.67M |
| June 30, 2024 | -232.34M |
| March 31, 2024 | -228.12M |
| December 31, 2023 | -204.17M |
| September 30, 2023 | -157.17M |
| June 30, 2023 | -102.27M |
| March 31, 2023 | -48.85M |
| December 31, 2022 | -21.45M |
| September 30, 2022 | 26.31M |
| June 30, 2022 | 103.78M |
| March 31, 2022 | 158.05M |
| December 31, 2021 | 209.15M |
| September 30, 2021 | 325.79M |
| June 30, 2021 | 260.58M |
| March 31, 2021 | 371.00M |
| December 31, 2020 | 422.18M |
| September 30, 2020 | 451.66M |
| June 30, 2020 | 395.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 458.36M |
| December 31, 2019 | 516.14M |
| September 30, 2019 | 594.45M |
| June 30, 2019 | 629.03M |
| March 31, 2019 | 489.22M |
| December 31, 2018 | 509.20M |
| September 30, 2018 | 471.31M |
| June 30, 2018 | 495.53M |
| March 31, 2018 | 499.52M |
| December 31, 2017 | 528.47M |
| September 30, 2017 | 571.50M |
| June 30, 2017 | 230.10M |
| March 31, 2017 | 131.70M |
| December 31, 2016 | 155.84M |
| September 30, 2016 | 178.34M |
| June 30, 2016 | 193.11M |
| March 31, 2016 | 156.95M |
| December 31, 2015 | 177.55M |
| September 30, 2015 | 217.28M |
| June 30, 2015 | 253.62M |
| March 31, 2015 | 184.62M |
| December 31, 2014 | 221.40M |
| September 30, 2014 | 81.77M |
| June 30, 2014 | 111.99M |
| March 31, 2014 | 63.79M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vericel Corp. | 370.04M |
| Capricor Therapeutics, Inc. | 246.22M |
| ARS Pharmaceuticals, Inc. | 12.51M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 101.08M |
| Total Liabilities (Quarterly) | 109.22M |
| Current Ratio | 2.687 |
| Net Debt Paydown Yield | 59.68% |